Table of contents

Clinical and epidemiological research

• Extended report: Impact of cane use on pain, function, general health and energy expenditure during gait in patients with knee osteoarthritis: a randomised controlled trial (29 November, 2011) Free

  A Jones, P G Silva, A C Silva, M Colucci, A Tuffanin, J R Jardim, J Natour
• Extended report: Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study (14 September, 2011)

  M J H Boumans, J G A Houbiers, P Verschueren, H Ishikura, R Westhovens, E Brouwer, B Rojkovich, S Kelly, M den Adel, J Isaacs, H Jacobs, J Gomez-Reino, G M Holtkamp, A Hastings, D M Gerlag, P P Tak
• Extended report: In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial (19 September, 2011)

  Hamed Rezaei, Saedis Saevarsdottir, Kristina Forslind, Kristina Albertsson, Helena Wallin, Johan Bratt, Sofia Ernestam, Pierre Geborek, Ingemar F Pettersson, Ronald F van Vollenhoven
• Extended report: The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis (14 September, 2011)

  Cécile L Overman, Ercolie R Bossema, Henriët van Middendorp, Leoniek Wijngaards-de Meij, Suzanne MM Verstappen, Marcia Bulder, Johannes WG Jacobs, Johannes WJ Bijlsma, Rinie Geenen
• Extended report: Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study (26 September, 2011)

  Yusuf Yazici, Jeffrey R Curtis, Akgun Ince, Herbert Baraf, Raymond L Malamet, Lichen L Teng, Arthur Kavanaugh
• Extended report: Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial (13 October, 2011)

  Jeffrey R Curtis, Shuo Yang, Lang Chen, Grace S Park, Bojena Bitman, Brian Wang, Iris Navarro-Millan, Arthur Kavanaugh
• Extended report: Disability in rheumatoid arthritis in the era of biological treatments (27 September, 2011)

  Eswar Krishnan, Bharathi Lingala, Bonnie Bruce, James F Fries
• Extended report: The association between smoking and the development of psoriatic arthritis among psoriasis patients (27 September, 2011)

  Lihi Eder, Sutha Shanmugarajah, Arane Thavaneswaran, Vinod Chandran, Cheryl F Rosen, Richard J Cook, Dafna D Gladman
• Extended report: A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach (29 September, 2011)

  Susanne Schmitz, Roisin Adams, Cathal D Walsh, Michael Barry, Oliver FitzGerald
• Extended report: Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay (21 October, 2011)

  Der-Yuan Chen, Gwan-Han Shen, Yi-Ming Chen, Hsin-Hua Chen, Chia-Wei Hsieh, Joung-Liang Lan
• Concise report: Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoid arthritis (27 September, 2011)

  A Krabben, T W J Huizinga, A H M van der Helm-van Mil
• Concise report: Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called ‘seronegative APS’) (27 September, 2011)

  Jose Luis Rodriguez-Garcia, Maria Laura Bertolaccini, Maria Jose Cuadrado, Giovanni Sanna, Oier Ateka-Barrutia, Munther A Khamashta
• Concise report: The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study (21 November, 2011)

  M van den Broek, L Dirven, NB Klarenbeek, THE Molenaar, KH Han, PJSM Kerstens, TWJ Huizinga, BAC Dijkmans, CF Allaart
• Concise Report: The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH (13 October, 2011)

  Philip J Clements, Mary Tan, Vallerie V McLaughlin, Ronald J Oudiz, Victor F Tapson, Richard N Channick, Lewis J Rubin, Anatoly Langer